GirishDhallMD

Pediatric Hematology & Oncology • Birmingham, AL

Professor, Pediatrics, University of Alabama at Birmingham

Overview of Dr. Dhall

Dr. Girish Dhall is a pediatric hematologist/oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Children's of Alabama and University of Alabama Hospital. He received his medical degree from Grant Medical College and has been in practice 23 years. He is one of 31 doctors at Children's of Alabama and one of 23 doctors at University of Alabama Hospital who specialize in Pediatric Hematology & Oncology. He has more than 100 publications and over 500 citings.

Office
1600 7th Avenue South
Birmingham, AL 35233
Book by Phone+1(205) 973-4529
Is this information wrong?

Education & Training

NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Westchester Medical CenterResidency, Pediatrics, 1997 - 2000
Grant Medical CollegeClass of 1994

Certifications & Licensure

AL State Medical License 2019 - 2024
CA State Medical License 2005 - 2019
FL State Medical License 2013 - 2015
NJ State Medical License 2003 - 2007
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Start of enrollment: 2004 Mar 01
Unknown status
Phase 3
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
Completed
Phase 1
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19
Active, not recruiting
Phase 1, Phase 2
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) Start of enrollment: 2010 Aug 01
Completed
Phase 2
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
Completed
Phase 1
Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Start of enrollment: 2014 Apr 01
Terminated
Phase 2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Start of enrollment: 2013 Aug 01
Completed
Phase 1
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma Start of enrollment: 2017 Apr 04
Terminated
Early Phase 1
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
Completed
Phase 1
Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04
Recruiting
Not Applicable
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Start of enrollment: 2020 Oct 02
Recruiting
Phase 1
Roles: Contact
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Start of enrollment: 2020 Dec 09
Recruiting
Phase 1
Roles: Contact
Combination Therapy for the Treatment of Diffuse Midline Gliomas Start of enrollment: 2021 Oct 20
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01
Active, not recruiting
Phase 4
Roles: Contact, Study Chair
Join now to see all

Publications & Presentations

PubMed

Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Margaret Shatara, Megan Blue, Joseph Stanek, Yin A Liu, Daniel M Prevedello, Pierre Giglio, Vinay K Puduvalli, Sharon L Gardner, Jeffrey C Allen, Kenneth K Wong, Marvi...> ;Neuro-Oncology Practice. 2024 Apr 1
Children's Oncology Group's 2023 blueprint for research: Young investigators.
Adam J Esbenshade, Lisa S Kahalley, Birte Wistinghausen, Thomas Cash, Reto M Baertschiger, Sara Zarnegar-Lumley, Adam Green, Girish Dhall> ;Pediatric Blood & Cancer. 2023 Sep 1
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Jaclyn A Biegel, Girish Dhall, Nathan J Robison, Kaaren Waters, Palak Patel, Rober...> ;Oncotarget. 2023 May 19
4 citations
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J ...> ;Neuro-Oncology. 2023 Aug 3
7 citations
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
Craig Erker, Martin Mynarek, Simon Bailey, Claire M Mazewski, Lorena Baroni, Maura Massimino, Juliette Hukin, Dolly Aguilera, Andrea M Cappellano, Vijay Ramaswamy, Alv...> ;Journal of Clinical Oncology. 2023 Apr 1
3 citations
Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach.
Kee Kiat Yeo, Sumanth Nagabushan, Girish Dhall, Mohamed S Abdelbaki> ;Neoplasia. 2023 Feb 1
2 citations
Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antige...
Ashok Panigrahy, Regina I Jakacki, Ian F Pollack, Rafael Ceschin, Hideho Okada, Marvin D Nelson, Gary Kohanbash, Girish Dhall, Stefan Bluml> ;Cancers. 2022 Dec 5
1 citations
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: ...
Jason R Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shengjie Wu, Azra H Ligon, Neal Ian Lindeman, Anuradha Banerjee, Roger Packer, Lindsay B Kilburn, Ian F Poll...> ;Neuro-Oncology. 2022 Aug 1
6 citations
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminoma...
Erin S Murphy, Girish Dhall, Jason Fangusaro, Ute Bartels, Maryam Fouladi, Dennis Shaw, Soumen Khatua, Chris Williams Hughes, Ashok Panigraphy, Myrsini Ioakeim-Ioannid...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 May 1
2 citations
Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North America...
Giovanni Morana, Dennis Shaw, Shannon M MacDonald, Claire Alapetite, Thankamma Ajithkumar, Aashim Bhatia, Hervé Brisse, Camilo Jaimes, Thomas Czech, Girish Dhall, Jaso...> ;The Lancet. Oncology. 2022 May 1
4 citations
Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the Children's Oncology Group.
David Y Mak, Zain Siddiqui, Zhihui Amy Liu, Hitesh Dama, Shannon M MacDonald, Shengjie Wu, Erin S Murphy, Matthew D Hall, Victor Malkov, Arzu Onar-Thomas, Sameera Ahme...> ;Pediatric Blood & Cancer. 2022 Sep 1
3 citations
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials.
Adriana Fonseca, Cecile Faure-Conter, Matthew J Murray, Jason Fangusaro, Shivani Bailey, Stewart Goldman, Soumen Khatua, Didier Frappaz, Gabriele Calaminus, Girish Dha...> ;Neuro-Oncology. 2022 Nov 2
4 citations
Phase II Trial of Response-Based Radiation Therapy for Patients with Localized Germinoma: A Children's Oncology Group Study.
Ute Bartels, Arzu Onar-Thomas, Sunita K. Patel, Dennis Shaw, Jason Fangusaro, Girish Dhall, Mark M. Souweidane, Aashim Bhatia, Leanne Embry, Christine L. Trask, Erin S...> ;Neuro-Oncology. 2021 Nov 29
9 citations
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
D. Frappaz, Girish Dhall, Matthew J. Murray, Stewart Goldman, C Faure Conter, Jeffrey C. Allen, RD Kortmann, D Haas-Kogen, Giovanni Morana, Jonathan L. Finlay, James N...> ;Neuro-Oncology. 2021 Nov 1
Potential Role of Carbon Ion Radiotherapy in Chromothripsis-induced Medulloblastoma and Other Malignancies.
Gregory K. Friedman, Girish Dhall> ;Neuro-Oncology. 2021 Oct 4
2 citations
How to be successful in an academic interview in pediatric oncology: A survey of Children's Oncology Group (COG) and International Society of Paediatric Oncology (SIOP...
Gemma Bryan, Jessica E Morgan, Girish Dhall, Adam J. Esbenshade> ;Pediatric Blood & Cancer. 2021 Mar 1
27 citations
Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma
Rahul Kumar, Kyle S. Smith, Maximilian Deng, Colt Terhune, Giles W. Robinson, Brent A. Orr, Anthony P. Y. Liu, Tong Lin, Catherine A. Billups, Murali Chintagumpala, Da...> ;Journal of Clinical Oncology. 2021 Jan 27
1 citations
Primary Primitive Neuroectodermal Tumor (PNET) of the Spine With t(11;22): Report of 3 Cases and Review of Literature.
Ashley Margol, Chenue Abongwa, Girish Dhall> ;Journal of Pediatric Hematology/oncology. 2021 Jan 20
22 citations
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
David Van Mater, Sridharan Gururangan, Oren J. Becher, Olivia Campagne, Sarah Leary, Joanna J. Phillips, Jie Huang, Tong Lin, Tina Young Poussaint, Stewart Goldman, Pa...> ;Pediatric Blood & Cancer. 2021 Jan 6
3 citations
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults
Jianling Ji, Kristiyana Kaneva, Matthew C. Hiemenz, Girish Dhall, Tom B. Davidson, Anat Erdreich-Epstein, Debra Hawes, Kyle Hurth, Ashley Margol, Anna Mathew, Nathan R...> ;Neuro-Oncology Advances. 2021 Jan 1
46 citations
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.
Girish Dhall, Sharon H. O'Neil, Lingyun Ji, Kelley Haley, Ashley M Whitaker, Marvin D. Nelson, Floyd H. Gilles, Sharon Gardner, Jeffrey C. Allen, Albert Cornelius, Kam...> ;Neuro-Oncology. 2020 Dec 18
4 citations
Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series.
John R. Crawford, Marlon Garzo Saria, Girish Dhall, Ashley Margol, Santosh Kesari> ;Cureus. 2020 Oct 5
11 citations
Neuropsychological outcomes on Head Start III: a prospective, multi-institutional clinical trial for young children diagnosed with malignant brain tumors.
Sharon H. O'Neil, Ashley M Whitaker, Kimberly Kayser, Mary Baron Nelson, Jonathan L. Finlay, Girish Dhall, Stephen A. Sands> ;Neuro-Oncology Practice. 2020 Jun 5
47 citations
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Tabitha Cooney, Kenneth J. Cohen, Carolina V. Guimaraes, Girish Dhall, James L. Leach, Maura Massimino, Alessandra Erbetta, Luisa Chiapparini, Fatema Malbari, Kim Kram...> ;The Lancet. Oncology. 2020 Jun 1
40 citations
Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).
Theodore Nicolaides, Kellie J. Nazemi, John Robertson Crawford, Lindsay Kilburn, Jane E. Minturn, Amar Gajjar, Karen Gauvain, Sarah Leary, Girish Dhall, Mariam Aboian,...> ;Oncotarget. 2020 May 26
Join now to see all

Press Mentions

UAB’s Coronavirus Testing Site Receives $200,000 from HyundaiApril 4th, 2020
Siblings Diagnosed 13 Days Apart with Brain Cancer Finish TreatmentAugust 2nd, 2019
Career Briefs: Girish Dhall, M.D., Has Been Named as Division Director for the Hematology-Oncology and Blood Marrow Transplantation ProgramJanuary 26th, 2019